MAIA Biotechnology Inc
MAIA
Get informed when a big investor buys or sells
+ FollowMarket Cap$85.12M
Close$
$0.43
68.7% downside
Current Fair Value
68.7% downsideOvervalued by 68.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $85.12 Million |
|---|---|
| Enterprise Value | $50.71 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.7 |
| Beta | 0.24 |
| Outstanding Shares | 32,115,000 |
Return
| Return on Equity | -87.34% |
|---|---|
| Return on Assets | -68.65% |
| Return on Invested Capital | -87.37% |
Valuation & Multiples
| P/E Ratio | -1.85 |
|---|---|
| PEG | -4.52 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 40.95%▲ 33.37% |
|---|---|
| Total Invested | $18.40M▲ 349.85% |
| Investors Holding | 32▲ 6.00% |
ESG Score
No data